#innovationIOWA Merck to buy Ames-based Harrisvaccines

Merck to buy Ames-based Harrisvaccines
Merck & Co. Inc.’s animal health unit will buy Ames-based privately held Harrisvaccines Inc. to expand its portfolio of animal vaccines as the U.S. livestock industry seeks new defenses against diseases, Reuters reported. The companies did not report the terms of the sale, which is expected to close by the end of the year. Harrisvaccines gained fame for developing a vaccine to fight porcine epidemic diarrhea virus. In October, the firm signed a contract with the U.S. Department of Agriculture to supply avian influenza vaccine for poultry. The USDA is preparing for another potential outbreak of the virus later this year.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s